drugset / Trial / NCT00490945
Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the safety and efficacy of VEC-162 compared to matching placebo on circadian phase shift and sleep parameters.
Timeline
- Start
- 2004-07
- Primary completion
- 2005-03
- Completion
- 2005-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tasimelteon | Small molecule | 10 mg | — |
| Subject | tasimelteon | Small molecule | 20 mg | — |
| Subject | tasimelteon | Small molecule | 50 mg | — |
| Subject | tasimelteon | Small molecule | 100 mg | — |